Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Public ClinicalTrials.gov record NCT06087458. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 1/2a Study of VOY-101 in Subjects With Advanced Non-Neovascular Age-Related Macular Degeneration (JOURNEY)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Phase 1 safety study of VOY-101 is comprised of escalating dose Cohorts, followed by a Phase 2 at the recommended phase 2 dose.
Study identification
- NCT ID
- NCT06087458
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 60 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 20, 2023
- Primary completion
- Sep 30, 2027
- Completion
- May 31, 2028
- Last update posted
- Aug 16, 2026
2023 – 2028
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Macula Institute of AZ | Scottsdale | Arizona | 85255 | — |
| Retina Consultants San Diego | Poway | California | 92064 | — |
| Retinal Consultants Medical Group | Sacramento | California | 95825 | — |
| Ophthalmic Consultants of Boston | Boston | Massachusetts | 02114 | — |
| The Retina Institute | St Louis | Missouri | 63128 | — |
| Mid Atlantic Retina | Cherry Hill | New Jersey | 08034 | — |
| Retina Northwest | Portland | Oregon | 97221 | — |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | — |
| Austin Research Center for Retina | Austin | Texas | 78705 | — |
| Star Retina | Fort Worth | Texas | 76132 | — |
| Retina Center of Texas | Southlake | Texas | 76092 | — |
| University of Utah John A. Moran Eye Center | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06087458, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06087458 live on ClinicalTrials.gov.